ARCHIVES

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation

July 22, 1994

Canadian NCI Plans Review Of National Breast Screening Study

February 24, 1995

New Drugs And Older Ones In New Uses Show Progress Against Several Cancers

April 25, 2008

Abstract Of Papers From ACTR Meeting

October 22, 1976

Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups

September 30, 1988